Endometrial contraception: Modulation of molecular determinants of uterine receptivity

Steroids

Volumn 65, Issue 10-11, 2000, Pages 783-794

  Puri, Chander P ^a   Katkam, Rajendra R ^a   Sachdeva, Geetanjali ^a   Patil, Vishakha ^a   Manjramkar, Dhananjay D ^a   Kholkute, Sanjiva D ^a  

^a Institute for Research in Reproduction India   (India)

Author keywords

Estrogen receptor; Integrins; Leukemia inhibitory factor; Onapristone; Progesterone receptor; Transforming growth factor ; Transforming growth factor receptor; Uterine receptivity

Indexed keywords

ANTIGESTAGEN; ESTROGEN RECEPTOR; INTEGRIN; LEUKEMIA INHIBITORY FACTOR; ONAPRISTONE; PROGESTERONE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTRACEPTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HISTOLOGY; HORMONE SENSITIVITY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MACACA; MENSTRUAL CYCLE; NIDATION; NONHUMAN; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION;

ANIMALS; CELL ADHESION MOLECULES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; FEMALE; GONANES; GROWTH INHIBITORS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MACACA RADIATA; MENSTRUAL CYCLE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTORS;

ANIMALIA; MACACA; PRIMATES;

EID: 0033645402     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00192-6     Document Type: Article

References (46)

1. Morphological and histochemical factors related to implantation
2. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion
3. Luteal control of endometrial receptivity and its modification by progesterone antagonists
4. Modification of endometrial cell biology using progesterone antagonists to manipulate the implantation window
5. Onapristone (ZK 98.299): A potential antiprogestin for endometrial contraception
6. The implantation window: Basic and clinical aspects
7. The endometrial cell surface and implantation. Expression of the polymorphic mucin MUC-1 and adhesion molecules during the endometrial cycle
8. The polymorphic mucin MUC-1 in human endometrium is regulated with maximal expression in the implantation phase
9. Synthesis of placental protein 12 by human endometrium
10. Prolactin production by human endometrium during the menstrual cycle
11. Secretory endometrium synthesizes placental protein 14
12. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle
13. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy
14. Cytokines in implantation
15. Site and menstrual cycle dependent expression of proteins of the TNF receptor family, and BCL-2 oncoprotein and phase specific production of TNF-α in human endometrium
16. The progressive rise in the expression of α crystallin b chain in human endometrium is initiated during the implantation window: Modulation of gene expression by steroid hormones
17. Expression of interleukin 1, interleukin 6 and tumor necrosis factor α in mouse uterus during the peri-implantation period of pregnancy
18. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist (IL-1ra)
19. Uterine expression of Leukemia inhibitory factor (LIF) coincides with the onset of blastocyst implantation
20. Leukemia inhibitory factor and the regulation of blastocyst implantation
21. Leukemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time
22. In vitro differential effects of the antiglucocorticoid RU 486 on the release of lymphokines from mitogen activated normal human lymphocytes
23. Expression pattern of integrin adhesion molecules in endometriosis and human endometrium
24. 3 and α(v) are apically distributed in endometrial epithelium
25. Expression of integrin adhesion molecules in endometrium and endometriosis
26. Induction of menstruation by antiprogesterone ZK 98.299 in cycling bonnet monkeys
27. The effects of postovulatory administration of onapristone on the development of a secretory endometrium
28. Effect of early luteal phase administration of mifepristone (RU486) on Leukemia inhibitory factor, transforming growth factor β and vascular endometrial growth factor in the implantation stage endometrium of the rhesus monkey
29. Sequence and expression of human estrogen receptor complementary DNA
30. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA
31. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid Leukemia inhibitory factor
32. Differential gene expression by estrogen and progesterone in the primate endometrium
33. Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium
34. Mechanism of action and clinical effects of antiprogestins on the non pregnant uterus
35. Blastocyst implantation depends on maternal expression of Leukemia inhibitory factor
36. Expression of Leukemia inhibitory factor in human endometrium and placenta
37. Progestin dependent stimulation of the human Leukemia inhibitory factor promoter in SKUT-IB uterine tumor cells
38. Modulation of Leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium
39. Expression of transforming growth factor-β (TGF β) isoforms and TGFβ type II receptor messenger ribonucleic acid and protein and the effect of TGFβ on endometrial stromal cell growth and protein degradation in vitro
40. Human uterine tissue throughout the menstrual cycle expresses transforming growth factor β 1 (TGF β 1), TGF β 2, TGF β 3, and TGF β type II receptor messenger ribonucleic acid and protein and contains ((125)I) TGF β 1-binding sites
41. Inhibition of growth by transforming growth factor β following fusion of two non responsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses
42. The transforming growth factor β family
43. Mechanism of activation of transforming growth factor β1 by plasmin
44. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture
45. Estrogen and progesterone receptor mRNA are expressed in distinct pattern in male primate reproductive organs